Answers are grounded in this paper and cite their sources.
Review highlights advances in magnetically controlled nanocarriers enhancing targeted delivery and combination therapies in medicine.
Introduction:: Conventional drug delivery systems continue to face significant limitations, including poor bioavailability, lack of site specificity, and unintended systemic toxicity. These challenges are particularly evident in the treatment of complex diseases such as cancer and neurological disorders. In this context, magnetically guided nanocarriers have emerged as a promising strategy, offering the ability to direct therapeutic agents and control their release using external magnetic fields. Methods:: This review summarizes recent advances in the design and biomedical application of magnetically controlled nanocarriers. Relevant literature was collected from major scientific databases, with emphasis on synthesis strategies, surface functionalization, and their integration into combination therapy and theranostic platforms. Results:: Magnetic nanostructures, particularly superparamagnetic iron oxide nanoparticles (SPIONs), exhibit favorable properties such as magnetic responsiveness, biocompatibility, and tunable surface chemistry. These features support targeted delivery, externally triggered drug release, and real-time imaging using MRI. Applications extend across cancer therapy, neurological disorders, metabolic diseases, and infectious conditions. Recent developments also highlight hybrid systems combining photothermal, photodynamic, and immunotherapeutic approaches to improve treatment outcomes. Discussion:: Despite notable progress, several challenges remain, including limited penetration in deep tissues, rapid clearance by the immune system, issues with large-scale reproducibility, and regulatory constraints. Emerging strategies such as biodegradable coatings, improved material design, and integration with computational optimization may help address these limitations. Conclusion:: Magnetically controlled nanocarriers represent a versatile platform for precision medicine, enabling targeted, controlled, and multifunctional therapeutic delivery. Continued interdisciplinary efforts and clinical validation will be essential for their successful translation into clinical practice.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: